Chipiron is a developer of advanced portable MRI machines that utilize cutting-edge quantum detectors to generate high-resolution three-dimensional anatomical images. By operating at ultra-low magnetic fields, these machines are designed to be lightweight and cost-effective, significantly reducing the price compared to traditional MRI systems. Chipiron's technology aims to enhance disease detection, diagnosis, and treatment monitoring, particularly for brain-related conditions, thereby assisting healthcare institutions in improving patient outcomes and potentially decreasing fatality rates associated with these ailments.
Nuada is a vertically integrated company specializing in carbon capture technology aimed at decarbonizing heavy industries. The firm develops next-generation point-source capture solutions designed to facilitate energy-efficient CO2 filtration for industrial emitters in sectors that are difficult to decarbonize. By offering innovative technologies, Nuada enables these industries to meet their Net Zero targets while minimizing financial impacts. The company is committed to providing effective environmental solutions that address the challenges of carbon emissions in various industrial applications.
VarmX
Venture Round in 2025
VarmX is a pharmaceutical spin-off from the Leiden University Medical Center, focused on the development and manufacturing of therapeutic proteins aimed at restoring blood clotting in patients experiencing bleeding. The company's lead product, PseudoXa, is a modified recombinant human coagulation factor X that can promptly reinstate blood clotting in patients using direct factor Xa anticoagulants, such as rivaroxaban, apixaban, and edoxaban. These anticoagulants, commonly prescribed for the prevention and treatment of thrombosis and stroke, often lead to severe bleeding as a side effect. PseudoXa addresses this critical issue by effectively stopping and preventing bleeding, thereby enhancing the safety of anticoagulant therapy for millions of patients worldwide.
Iktos is a French company specializing in artificial intelligence-driven solutions for medicinal chemistry and new drug discovery. It offers SaaS platforms Makya™ for generative drug design and Spaya™ for retrosynthesis, accelerating pharmaceutical R&D. Iktos also develops AI-driven synthesis automation platform Iktos Robotics and has its own drug pipeline targeting oncology and autoimmune diseases.
Esencia Foods
Grant in 2025
Esencia Foods is a food processing company that creates sustainable fish and seafood alternatives using mushroom mycelium and solid‑state fermentation. Its products are high in protein, fiber, and omega‑3, and are vegan, non‑GMO, and free of antibiotics. The company focuses on delivering healthy, nutrient‑rich alternatives to traditional seafood.
Brineworks
Seed Round in 2025
Brineworks is a technology company specializing in ocean-based carbon capture. It operates a high-efficiency saltwater electrolyzer that extracts CO2 directly from seawater, generating green hydrogen as a byproduct. This process enables businesses to access large-scale, affordable carbon removal solutions, contributing to responsible climate change mitigation efforts.
Vivalyx
Seed Round in 2025
Vivalyx is a healthcare company focused on improving organ transplantation outcomes. It specializes in developing a cost-effective solution for preserving organs, aiming to enhance their vitality and increase the available number for transplantation. The company's technology eliminates the need for donor blood or human products, making it a versatile option for various preservation applications. By doing so, Vivalyx supports doctors in extending organ viability, ultimately benefiting patients suffering from organ failure worldwide.
Vivalyx is a healthcare company focused on improving organ transplantation outcomes. It specializes in developing a cost-effective solution for preserving organs, aiming to enhance their vitality and increase the available number for transplantation. The company's technology eliminates the need for donor blood or human products, making it a versatile option for various preservation applications. By doing so, Vivalyx supports doctors in extending organ viability, ultimately benefiting patients suffering from organ failure worldwide.
SEMRON is a technology company founded in 2020 by Aron Kirschen and Kai-Uwe Demasius, specializing in the development of advanced artificial intelligence inference chips. The company focuses on creating AI chips that feature an exceptionally small footprint while maintaining high levels of computing power. Utilizing proprietary technology, SEMRON emphasizes energy-efficient operations and offers complementary metal oxide semiconductors as well as compatible semiconductor technology. This innovative approach enables clients to leverage AI chips that not only perform complex computations but also occupy less physical space, positioning SEMRON as a leader in the semiconductor industry.
Quobly is a developer of quantum computing semiconductors focused on creating and marketing a universal large-scale quantum computer. By utilizing established semiconductor industry procedures, the company aims to commercialize quantum computers based on silicon. Quobly's technology is designed to address complex problems, such as optimizing energy distribution and computing chemical properties, which can accelerate the development of new drugs. The company provides clients with customized quantum computing solutions that leverage proven semiconductor processes to meet their specific needs.
DeepKeep develops cybersecurity software to protect artificial intelligence and large language model systems from risks and cyber threats. Its platform covers the entire AI deployment lifecycle, from individual models to complex pipelines, with integrated tools that automatically enhance security and trustworthiness, including risk assessment and detection of hallucinations. Built for AI-native security, the solution supports vision data models, large language models, and tabular models, enabling scalable, reliable, and transparent AI deployments.
DeepKeep
Seed Round in 2025
DeepKeep develops cybersecurity software to protect artificial intelligence and large language model systems from risks and cyber threats. Its platform covers the entire AI deployment lifecycle, from individual models to complex pipelines, with integrated tools that automatically enhance security and trustworthiness, including risk assessment and detection of hallucinations. Built for AI-native security, the solution supports vision data models, large language models, and tabular models, enabling scalable, reliable, and transparent AI deployments.
AirForestry
Venture Round in 2025
AirForestry innovates forest management by thinning forests from the air using electric drones. This method reduces carbon emissions from traditional forestry work while increasing a forest's carbon sequestration capacity by freeing up land previously used for access roads.
Noah Labs
Seed Round in 2025
Noah Labs develops innovative technology aimed at the early detection of cardiovascular diseases through voice analysis. Utilizing advanced machine learning software, the company has created a digital health platform that allows patients to record their voices using a smartphone. This platform incorporates patient monitoring and digital biomarkers, providing personalized and predictive virtual care in the comfort of their homes. By focusing on voice-based diagnostics, Noah Labs seeks to empower individuals with cardiovascular conditions to lead healthier and longer lives.
Magneto Thrombectomy
Venture Round in 2025
Developer of a revolutionary thrombectomy device designed specifically for treating ischemic stroke. The company's innovative technology enables efficient and safe removal of blood clots from large to small vessels, even in distal regions of the brain, improving patient outcomes.
TetraKit Technologies
Seed Round in 2025
TetraKit Technologies is a Copenhagen-based company founded in 2021 that specializes in a click chemistry-based radiochemical platform aimed at developing therapeutics for metastatic cancer. The company offers a targeted radionuclide therapy and nuclear imaging platform for cancer diagnosis, utilizing radiopharmaceuticals such as fluorine-18 and astatine-211 for positron emission tomography (PET) imaging and targeted alpha-radionuclide therapy. TetraKit's innovative approach incorporates proprietary click chemistry and a modular design, which allows for rapid and mild labeling conditions across a variety of molecules. This platform enhances the efficiency of production processes in the field of radiopharmaceuticals, enabling medical professionals to leverage advanced technologies in cancer treatment and imaging.
Easelink
Venture Round in 2025
Easelink develops and industrializes conductive charging technologies for electric vehicles, aiming to automate and accelerate the charging process. It centers on MATRIX CHARGING, an automated conductive charging system with no moving parts outside the vehicle, designed to be stationary and scalable. The technology uses a charging pad that enables automatic direct physical connection as soon as a vehicle parks on top, eliminating the need for manual plugging and enabling convenient, efficient EV charging.
NextKidney is a medical device company that specializes in the development of portable and cost-effective solutions for hemodialysis treatment. Its flagship product, Neokidney, empowers patients by enabling them to perform dialysis at home or on the go, thereby restoring their autonomy and freedom. The Neokidney device is compact enough to fit on a nightstand, minimizing its intrusiveness in personal living spaces. Unlike traditional dialysis systems, which require large fluid volumes, Neokidney utilizes a sorbent cartridge to regenerate dialysis fluid, needing only 5 liters of fluid in bags. This innovative approach simplifies the logistics of dialysis, allowing patients to maintain their social and professional lives without the burden of extensive infrastructure or fluid management.
IXI is a company focused on advancing optical eyeglasses technology to enhance vision. It specializes in innovative lenses designed to offer a wide and clear field of view for both near and intermediate distances, effectively addressing the shortcomings of conventional progressive lenses. By providing a farsighted eyeglass prescription, IXI enables users to read and work with optimal vision without the need for multifocal lenses or constant switching of eyeglasses. The company aims to modernize traditional eyeglass optics, ensuring that individuals can experience vision as nature intended.
TetraKit Technologies
Grant in 2025
TetraKit Technologies is a Copenhagen-based company founded in 2021 that specializes in a click chemistry-based radiochemical platform aimed at developing therapeutics for metastatic cancer. The company offers a targeted radionuclide therapy and nuclear imaging platform for cancer diagnosis, utilizing radiopharmaceuticals such as fluorine-18 and astatine-211 for positron emission tomography (PET) imaging and targeted alpha-radionuclide therapy. TetraKit's innovative approach incorporates proprietary click chemistry and a modular design, which allows for rapid and mild labeling conditions across a variety of molecules. This platform enhances the efficiency of production processes in the field of radiopharmaceuticals, enabling medical professionals to leverage advanced technologies in cancer treatment and imaging.
NannyML
Venture Round in 2025
NannyML develops enterprise software to monitor machine learning models in production, enabling decision-makers to understand how AI decisions evolve and how changes affect business outcomes. The platform detects data drift and concept drift, estimates potential model degradation, and provides actionable insights through a dashboard that communicates model decisions to both business and technical stakeholders. It focuses on bridging the gap between business use and AI, helping organizations keep ML systems reliable, maintain value, and act on insights. The company was founded in 2020 and is based in Leuven, Belgium.
VoxelSensors
Grant in 2025
VoxelSensors is a technology company specializing in advanced sensing solutions for spatial and empathic interfaces, targeting mobile, XR, and industrial applications. The company has developed proprietary Single Photon Active Event Sensor (SPAES) technology, which leverages Single-Photon Avalanche Diodes (SPADs) to create low-power, low-latency data pathways. This innovative system enables precise spatial awareness, gaze tracking, and intuitive interactions, meeting the needs of manufacturers in the consumer electronics sector. VoxelSensors’ products represent a new category of three-dimensional perception systems, capable of capturing data with minimal photon usage. By enhancing immersive and autonomous experiences, VoxelSensors significantly contributes to the growth of the Mobile and XR markets while addressing the increasing demand for sophisticated spatial and empathic applications across various industries.
Quobly is a developer of quantum computing semiconductors focused on creating and marketing a universal large-scale quantum computer. By utilizing established semiconductor industry procedures, the company aims to commercialize quantum computers based on silicon. Quobly's technology is designed to address complex problems, such as optimizing energy distribution and computing chemical properties, which can accelerate the development of new drugs. The company provides clients with customized quantum computing solutions that leverage proven semiconductor processes to meet their specific needs.
Delft Circuits
Grant in 2025
Delft Circuits manufactures specialized hardware for quantum engineers and industries. They offer in-house cleanroom fabrication, cryogenic high-frequency laboratories, and expertise in microwave design, engineering, and superconducting materials to enable customers to achieve scalable, high-performance Input/Output (I/O) solutions.
Codasip
Venture Round in 2025
Codasip Ltd. is a processor technology company based in Brno, Czech Republic, founded in 2006. The company specializes in providing intellectual property (IP) and electronic design automation (EDA) tools that facilitate the adoption of application-specific instruction set processors (ASIPs). Codasip's offerings include Codix, RISC-V, and custom processors, allowing system-on-chip developers to customize their products for competitive advantage. Through its design automation tools and an open architecture licensing model, Codasip enables clients to leverage the benefits of the RISC-V instruction set architecture. The company's technology is utilized in billions of devices worldwide, with a diverse customer base that includes notable names such as AMD, Mobileye, and Sigma Designs. Codasip has established strategic partnerships with various organizations, enhancing its capabilities and market reach.
Startric is a developer of innovative structural heart technology focused on treating tricuspid valve regurgitation. The company is creating a minimally invasive transcatheter repair device that replicates the successful edge-to-edge clover repair technique used in open-heart surgery. This device addresses issues related to reduced oxygenation, which can lead to significant health problems such as atrial fibrillation, heart failure, and decreased quality of life. By offering a safe and effective solution, Startric aims to make advanced cardiac care more accessible to a broader patient population, thereby improving overall health outcomes for individuals affected by these conditions.
Startric
Venture Round in 2025
Startric is a developer of innovative structural heart technology focused on treating tricuspid valve regurgitation. The company is creating a minimally invasive transcatheter repair device that replicates the successful edge-to-edge clover repair technique used in open-heart surgery. This device addresses issues related to reduced oxygenation, which can lead to significant health problems such as atrial fibrillation, heart failure, and decreased quality of life. By offering a safe and effective solution, Startric aims to make advanced cardiac care more accessible to a broader patient population, thereby improving overall health outcomes for individuals affected by these conditions.
SemiQon
Venture Round in 2025
SemiQon is a Finnish startup spun out from VTT Technical Research Centre. It specializes in developing silicon-based quantum processors using novel semiconductor qubit technology, aiming to advance the scalability and sustainability of quantum computing.
CorPower Ocean
Venture Round in 2025
CorPower Ocean AB, founded in 2009 and headquartered in Hägersten, Sweden, specializes in the development of high-efficiency wave energy converters (WECs). These devices are designed to harness energy from ocean waves, utilizing a heaving buoy connected to the seabed with a taut mooring line. This innovative design features a pneumatic pre-tension module that enhances performance by enabling a lightweight system with a high natural frequency of oscillation. CorPower's WECs offer a significant improvement in energy output, delivering five times more annual energy per ton compared to earlier wave power solutions, positioning them competitively against offshore wind in terms of cost. Currently, the company is conducting pilot projects in collaboration with Iberdrola and boasts a team with extensive expertise in energy generation, system engineering, and market dynamics, driving the advancement of renewable energy technologies.
CarbonX B.V., based in Amsterdam, the Netherlands, specializes in the manufacture of carbon networks and the development of innovative materials. The company focuses on creating advanced products tailored for various industries, including elastomers, automotive and aerospace thermoplastics, construction, energy, and sports and leisure thermosets. By supplying these new materials, CarbonX aims to contribute to the design and production of the next generation of high-performance materials across multiple sectors.
Easelink develops and industrializes conductive charging technologies for electric vehicles, aiming to automate and accelerate the charging process. It centers on MATRIX CHARGING, an automated conductive charging system with no moving parts outside the vehicle, designed to be stationary and scalable. The technology uses a charging pad that enables automatic direct physical connection as soon as a vehicle parks on top, eliminating the need for manual plugging and enabling convenient, efficient EV charging.
Invitris is a biotech company focused on developing protein-based drugs and manufacturing bacteriophages to combat antibiotic-resistant bacteria. The company specializes in synthesizing arbitrary phages within a single system, which allows for effective quality assessment, synthetic phage production, and quality control services. By enabling personalized diagnostics, Invitris aims to provide patients with targeted treatments for bacterial infections, ensuring both safety and practical application in the fight against resistant pathogens.
Delft Circuits
Venture Round in 2025
Delft Circuits manufactures specialized hardware for quantum engineers and industries. They offer in-house cleanroom fabrication, cryogenic high-frequency laboratories, and expertise in microwave design, engineering, and superconducting materials to enable customers to achieve scalable, high-performance Input/Output (I/O) solutions.
EnduroSat
Venture Round in 2025
EnduroSat designs and engineers spacecraft for business applications and space exploration missions. The company specializes in swarm/constellation satellite applications and offers customized satellites along with full-cycle mission support.
BioThrust
Seed Round in 2025
BioThrust develops customized gassing solutions for bioreactors.
CorPower Ocean
Grant in 2025
CorPower Ocean AB, founded in 2009 and headquartered in Hägersten, Sweden, specializes in the development of high-efficiency wave energy converters (WECs). These devices are designed to harness energy from ocean waves, utilizing a heaving buoy connected to the seabed with a taut mooring line. This innovative design features a pneumatic pre-tension module that enhances performance by enabling a lightweight system with a high natural frequency of oscillation. CorPower's WECs offer a significant improvement in energy output, delivering five times more annual energy per ton compared to earlier wave power solutions, positioning them competitively against offshore wind in terms of cost. Currently, the company is conducting pilot projects in collaboration with Iberdrola and boasts a team with extensive expertise in energy generation, system engineering, and market dynamics, driving the advancement of renewable energy technologies.
AirForestry innovates forest management by thinning forests from the air using electric drones. This method reduces carbon emissions from traditional forestry work while increasing a forest's carbon sequestration capacity by freeing up land previously used for access roads.
Robeaute is a research and development agency that develops neurosurgical microrobots that can adapt to different types of medical evidence.
Robeaute
Venture Round in 2025
Robeaute is a research and development agency that develops neurosurgical microrobots that can adapt to different types of medical evidence.
Noah Labs develops innovative technology aimed at the early detection of cardiovascular diseases through voice analysis. Utilizing advanced machine learning software, the company has created a digital health platform that allows patients to record their voices using a smartphone. This platform incorporates patient monitoring and digital biomarkers, providing personalized and predictive virtual care in the comfort of their homes. By focusing on voice-based diagnostics, Noah Labs seeks to empower individuals with cardiovascular conditions to lead healthier and longer lives.
CarbonX
Venture Round in 2025
CarbonX B.V., based in Amsterdam, the Netherlands, specializes in the manufacture of carbon networks and the development of innovative materials. The company focuses on creating advanced products tailored for various industries, including elastomers, automotive and aerospace thermoplastics, construction, energy, and sports and leisure thermosets. By supplying these new materials, CarbonX aims to contribute to the design and production of the next generation of high-performance materials across multiple sectors.
Founded in 2022, Holloid specializes in real-time, image-based monitoring of colloidal objects in industrial processes. Its platform enables continuous tracking and analysis of physical characteristics, motion, and interactions, benefiting food, pharma, and energy sectors by reducing costs, improving quality, and enhancing safety through data-driven insights.
Everox
Venture Round in 2025
C2CA Technology B.V., founded in 2016 and based in Utrecht, the Netherlands, specializes in innovative concrete recycling solutions. The company focuses on transforming waste concrete into sustainable building materials, effectively replacing virgin aggregates, sand, and cement. By utilizing advanced separation and quality control technologies, C2CA aims to create a circular concrete economy that mitigates significant CO2 emissions associated with traditional concrete production. Its mobile concrete recycling system not only reduces logistical challenges but also minimizes water and energy consumption in the recycling process. The company's demonstration site in Hoorn showcases its commitment to achieving 100% circular concrete and fostering a more sustainable future through eco-friendly construction practices.
TreeFrog Therapeutics
Venture Round in 2025
TreeFrog Therapeutics is a stem cell company focused on scalable production of stem cells for cell therapies. It develops and uses a proprietary end-to-end 3D bioreactor-based platform called C-Stem to enable scalable, cGMP-compliant manufacturing. Founded in 2018 and based in Pessac, France, the company aims to secure cell production and quality, accelerate clinical development, and improve market access by reducing treatment costs. The platform addresses manufacturing bottlenecks in the cell therapy sector, offering an integrated solution from cell culture to manufacturing readiness to support safe, affordable stem cell therapies.
Aindo specializes in generating synthetic data, enabling artificial intelligence to add value responsibly while respecting privacy. Its platform creates hyper-realistic yet artificial data, replacing personal information or balancing biased datasets for safe and fair analysis across sectors like healthcare, finance, and policymaking.
Invitris
Seed Round in 2025
Invitris is a biotech company focused on developing protein-based drugs and manufacturing bacteriophages to combat antibiotic-resistant bacteria. The company specializes in synthesizing arbitrary phages within a single system, which allows for effective quality assessment, synthetic phage production, and quality control services. By enabling personalized diagnostics, Invitris aims to provide patients with targeted treatments for bacterial infections, ensuring both safety and practical application in the fight against resistant pathogens.
Neurescue ApS, headquartered in Copenhagen, Denmark, specializes in developing innovative medical devices aimed at addressing cardiac arrest and hemorrhage. Established in 2014, the company has introduced its flagship product, the safeREBOA device, which is recognized as the first computer-aided aortic occlusion catheter designed to enhance the care of emergency patients. Neurescue's commitment lies in improving resuscitation rates and extending critical treatment time through advanced cardiovascular solutions. The organization is focused on advancing the clinical utility of its devices to ultimately save lives in emergency situations.
Hummink
Seed Round in 2025
Hummink is a company specializing in additive manufacturing technology, focusing on nano-printing solutions that enable precise design and manufacturing at the nanoscale. Founded in 2020 in Paris by Amin M'barki, Pascal Boncenne, Lydéric Bocquet, Alessandro Siria, and Antoine Nigues, Hummink utilizes a patented technology that integrates a nanometric pen with an oscillating microresonator. This innovative approach allows for the capillary deposition of various liquids, equipping clients in the semiconductor and molecular diagnostic industries with the capability to create large objects while maintaining exceptional resolution and precision on substrates ranging from millimetric to centimetric scales.
MyoPax develops advanced regenerative therapies using stem cells to address debilitating muscle illnesses.
NextKidney
Venture Round in 2025
NextKidney is a medical device company that specializes in the development of portable and cost-effective solutions for hemodialysis treatment. Its flagship product, Neokidney, empowers patients by enabling them to perform dialysis at home or on the go, thereby restoring their autonomy and freedom. The Neokidney device is compact enough to fit on a nightstand, minimizing its intrusiveness in personal living spaces. Unlike traditional dialysis systems, which require large fluid volumes, Neokidney utilizes a sorbent cartridge to regenerate dialysis fluid, needing only 5 liters of fluid in bags. This innovative approach simplifies the logistics of dialysis, allowing patients to maintain their social and professional lives without the burden of extensive infrastructure or fluid management.
Hummink is a company specializing in additive manufacturing technology, focusing on nano-printing solutions that enable precise design and manufacturing at the nanoscale. Founded in 2020 in Paris by Amin M'barki, Pascal Boncenne, Lydéric Bocquet, Alessandro Siria, and Antoine Nigues, Hummink utilizes a patented technology that integrates a nanometric pen with an oscillating microresonator. This innovative approach allows for the capillary deposition of various liquids, equipping clients in the semiconductor and molecular diagnostic industries with the capability to create large objects while maintaining exceptional resolution and precision on substrates ranging from millimetric to centimetric scales.
Premium Fertility
Grant in 2025
Premium Fertility develops an assisted reproductive technology for embryo transfer, featuring a direct embryo transfer system that integrates optical, microfluidic, and automated components to enable clinicians to place embryos with greater precision and consistency while addressing uncertainties in attachment.
Blykalla
Venture Round in 2025
Blykalla is a Swedish company focused on the development and production of advanced small modular reactors (SMRs). Drawing on more than 25 years of research, its reactor concepts aim to provide reliable baseload energy to support a fossil-free energy transition. The company develops lead-cooled reactor designs, featuring cores configured to achieve criticality with enriched uranium oxide fuels, enabling clients to develop, license, and operate small lead-cooled reactors in Sweden. Blykalla emphasizes safety and modularity, offering scalable power solutions for diverse sites while reducing carbon emissions.
Leyden Labs
Venture Round in 2025
Leyden Labs develops a Mucosal Protection Platform to protect against respiratory viruses, including influenza and coronaviruses. The company offers a portfolio of broad protective nasal sprays designed to reduce the risk of infection and limit transmission, aiming to improve public health through innovative protection methods. Its team combines biotechnology veterans with new talent to advance solutions that address common viral threats at the mucosal surface.
Superintelligence Computing Systems
Seed Round in 2025
Superintelligence Computing Systems are committed to bringing true automation to all industrial sectors through AGI technology with human-like learning capabilities.
PFx Biotech is a pioneering company that specializes in the development of alternative proteins using precision fermentation. They focus on producing human milk proteins, which are nourishing and contain beneficial bioactivities such as immune-boosting, anti-microbial, and anti-viral properties. By leveraging their fermentation platform, they aim to provide sustainable protein alternatives that can help reduce water consumption and greenhouse gas emissions, thereby promoting a more environmentally friendly and animal-free protein landscape.
Novobiom
Venture Round in 2025
Novobiom is a company focused on bioremediation, specifically designed to address persistent and pervasive pollutants in contaminated soil. Utilizing innovative mycoremediation technology, which employs mushrooms, Novobiom offers tailored solutions for soil pollution, effectively treating hazardous waste while promoting sustainability. In addition to its remediation services, the company provides consultation to enhance sustainability awareness and innovation, guiding industries in achieving their strategic environmental goals through biomimetic approaches.
eleQtron is a company that develops and operates quantum computers utilizing trapped ions, RF control, and Magnetic Gradient Induced Coupling (MAGIC). Its intermediate-scale quantum processors are designed to address near-term industrial applications in fields such as chemistry, life sciences, logistics, and finance. By leveraging advanced computing technology, eleQtron’s systems are capable of solving complex problems that conventional supercomputers struggle to manage, including performing parallel computations. The company focuses on implementing innovative concepts for scalable quantum processors, enabling users to tackle previously unsolvable challenges. eleQtron also offers its quantum computing capabilities through a subscription model, making cutting-edge technology accessible to various industries.
NannyML develops enterprise software to monitor machine learning models in production, enabling decision-makers to understand how AI decisions evolve and how changes affect business outcomes. The platform detects data drift and concept drift, estimates potential model degradation, and provides actionable insights through a dashboard that communicates model decisions to both business and technical stakeholders. It focuses on bridging the gap between business use and AI, helping organizations keep ML systems reliable, maintain value, and act on insights. The company was founded in 2020 and is based in Leuven, Belgium.
Superintelligence Computing Systems
Grant in 2025
Superintelligence Computing Systems are committed to bringing true automation to all industrial sectors through AGI technology with human-like learning capabilities.
C2CA Technology B.V., founded in 2016 and based in Utrecht, the Netherlands, specializes in innovative concrete recycling solutions. The company focuses on transforming waste concrete into sustainable building materials, effectively replacing virgin aggregates, sand, and cement. By utilizing advanced separation and quality control technologies, C2CA aims to create a circular concrete economy that mitigates significant CO2 emissions associated with traditional concrete production. Its mobile concrete recycling system not only reduces logistical challenges but also minimizes water and energy consumption in the recycling process. The company's demonstration site in Hoorn showcases its commitment to achieving 100% circular concrete and fostering a more sustainable future through eco-friendly construction practices.
OQ Technology
Venture Round in 2025
OQ Technology aims to disrupt satellite telecommunication for Internet-of-Things (IoT) and machine-to-machine communication. It develops a global satellite constellation dedicated to IoT, serving industries like Oil & Gas, Maritime, Industry 4.0, consumer IoT, and Transport. The company offers innovative low-cost connectivity solutions and high-value data analytics for remote asset management and tracking.
Spira Energy 's technology is focused on a new compressing air concept which creates unique high-efficiency opportunities.
MetisMotion
Venture Round in 2025
MetisMotion GmbH, founded in 2018 and headquartered in Munich, Germany, specializes in the development of advanced actuators designed for various industrial applications, including robotics, aviation, and automotive sectors. The company focuses on creating lightweight, high force-density actuators that enhance performance through significant reductions in weight and space. MetisMotion's technology integrates the advantages of solid-state actuators with traditional drive systems, facilitating the electrification of hydraulic systems to achieve greater force output and extended displacement capabilities. This innovative approach positions MetisMotion as a key player in driving efficiency and modernization within the actuator market.
OQ Technology
Grant in 2025
OQ Technology aims to disrupt satellite telecommunication for Internet-of-Things (IoT) and machine-to-machine communication. It develops a global satellite constellation dedicated to IoT, serving industries like Oil & Gas, Maritime, Industry 4.0, consumer IoT, and Transport. The company offers innovative low-cost connectivity solutions and high-value data analytics for remote asset management and tracking.
LiveEO
Venture Round in 2025
Founded in Berlin in 2017, LiveEO is a pioneering provider of insights-as-a-service. It leverages AI and satellite data to offer real-time earth observation applications, specializing in monitoring large-scale infrastructure such as railways, power lines, and pipelines. LiveEO's services enable clients to manage risks, enhance operational efficiency, and ensure infrastructure safety and sustainability.
Saveggy
Seed Round in 2025
Saveggy develops an edible, bio-based coating for fruit and vegetables, replacing plastic packaging while maintaining protective properties. This reduces food waste along supply chains and ensures compliance with EU regulations.
Lumo Analytics
Grant in 2025
Lumo Analytics is a technology company specializing in laser-based scanning and analysis solutions for mineral exploration and mining. The company offers a laser-induced breakdown spectroscopy (LIBS)-based drill core analysis system that facilitates rapid elemental and mineral analysis. This innovative technology allows for instant and on-site assessments, enabling geologists to make informed decisions in real-time. By streamlining the analysis and planning processes, Lumo Analytics aims to minimize environmental impact, reduce costs, and enhance the likelihood of significant discoveries in the mining sector. Through its advanced solutions, the company contributes to more efficient and sustainable practices in mineral exploration.
Sparxell is a manufacturer of innovative biobased pigments designed to provide vibrant colors and effects using cellulose materials with a high naturality index. The company specializes in dye-free pigments that mimic the physical structures found in nature, such as those seen in birds and butterflies, to achieve their striking colors. These pigments are entirely biodegradable, minimizing environmental impact and avoiding the use of metals or minerals like mica and titania. By offering a low-carbon and high-performance alternative to traditional materials, Sparxell enables businesses across various industries to pursue carbon neutrality more effectively while enhancing their product offerings.
NanoPhoria is a biotechnology company focused on cardiovascular therapies. It develops non-viral, nanoparticle-based drug delivery platforms designed to target the heart directly and improve the delivery of biologics, including peptides and RNAs. The company is pursuing tissue-directed delivery methods and inhalable formulations, with preclinical programs aimed at treating cardiovascular diseases such as heart failure with reduced ejection fraction. Its platform enables selective organ- and cell-level targeting to expand administration routes beyond traditional systemic delivery, supporting research and development to advance cardiovascular health.
eleQtron
Seed Round in 2025
eleQtron is a company that develops and operates quantum computers utilizing trapped ions, RF control, and Magnetic Gradient Induced Coupling (MAGIC). Its intermediate-scale quantum processors are designed to address near-term industrial applications in fields such as chemistry, life sciences, logistics, and finance. By leveraging advanced computing technology, eleQtron’s systems are capable of solving complex problems that conventional supercomputers struggle to manage, including performing parallel computations. The company focuses on implementing innovative concepts for scalable quantum processors, enabling users to tackle previously unsolvable challenges. eleQtron also offers its quantum computing capabilities through a subscription model, making cutting-edge technology accessible to various industries.
Veridi Technologies
Grant in 2025
Veridi Technologies develops innovative technology that enables farmers to detect plant diseases and pathogens at early stages. By leveraging computer vision and automated microscopy, the company optimizes laboratory diagnostics that are accurate, affordable, and scalable. This advanced approach not only facilitates the early identification of diseases but also helps analyze soil biodiversity. As a result, farmers can reduce their reliance on pesticides while improving crop yields, contributing to more sustainable agricultural practices.
Premium Fertility
Venture Round in 2025
Premium Fertility develops an assisted reproductive technology for embryo transfer, featuring a direct embryo transfer system that integrates optical, microfluidic, and automated components to enable clinicians to place embryos with greater precision and consistency while addressing uncertainties in attachment.
Astrape Networks
Seed Round in 2025
Astrape powers the future of datacenters: more bandwidth, less power.
Novobiom is a company focused on bioremediation, specifically designed to address persistent and pervasive pollutants in contaminated soil. Utilizing innovative mycoremediation technology, which employs mushrooms, Novobiom offers tailored solutions for soil pollution, effectively treating hazardous waste while promoting sustainability. In addition to its remediation services, the company provides consultation to enhance sustainability awareness and innovation, guiding industries in achieving their strategic environmental goals through biomimetic approaches.
MyoPax develops advanced regenerative therapies using stem cells to address debilitating muscle illnesses.
ATMOS Space Cargo
Grant in 2025
ATMOS Space Cargo specializes in developing and manufacturing space capsules for returning cargo from space, facilitating microgravity experiments, and transporting commercial products. Its platform offers re-entry technology and services, enabling reliable and cost-effective delivery solutions for life sciences research, in-space manufacturing, and transportation industries.
Magneto Thrombectomy
Grant in 2025
Developer of a revolutionary thrombectomy device designed specifically for treating ischemic stroke. The company's innovative technology enables efficient and safe removal of blood clots from large to small vessels, even in distal regions of the brain, improving patient outcomes.
IXI is a company focused on advancing optical eyeglasses technology to enhance vision. It specializes in innovative lenses designed to offer a wide and clear field of view for both near and intermediate distances, effectively addressing the shortcomings of conventional progressive lenses. By providing a farsighted eyeglass prescription, IXI enables users to read and work with optimal vision without the need for multifocal lenses or constant switching of eyeglasses. The company aims to modernize traditional eyeglass optics, ensuring that individuals can experience vision as nature intended.
NanoPhoria
Seed Round in 2025
NanoPhoria is a biotechnology company focused on cardiovascular therapies. It develops non-viral, nanoparticle-based drug delivery platforms designed to target the heart directly and improve the delivery of biologics, including peptides and RNAs. The company is pursuing tissue-directed delivery methods and inhalable formulations, with preclinical programs aimed at treating cardiovascular diseases such as heart failure with reduced ejection fraction. Its platform enables selective organ- and cell-level targeting to expand administration routes beyond traditional systemic delivery, supporting research and development to advance cardiovascular health.
VoxelSensors
Seed Round in 2025
VoxelSensors is a technology company specializing in advanced sensing solutions for spatial and empathic interfaces, targeting mobile, XR, and industrial applications. The company has developed proprietary Single Photon Active Event Sensor (SPAES) technology, which leverages Single-Photon Avalanche Diodes (SPADs) to create low-power, low-latency data pathways. This innovative system enables precise spatial awareness, gaze tracking, and intuitive interactions, meeting the needs of manufacturers in the consumer electronics sector. VoxelSensors’ products represent a new category of three-dimensional perception systems, capable of capturing data with minimal photon usage. By enhancing immersive and autonomous experiences, VoxelSensors significantly contributes to the growth of the Mobile and XR markets while addressing the increasing demand for sophisticated spatial and empathic applications across various industries.
PFx Biotech
Seed Round in 2025
PFx Biotech is a pioneering company that specializes in the development of alternative proteins using precision fermentation. They focus on producing human milk proteins, which are nourishing and contain beneficial bioactivities such as immune-boosting, anti-microbial, and anti-viral properties. By leveraging their fermentation platform, they aim to provide sustainable protein alternatives that can help reduce water consumption and greenhouse gas emissions, thereby promoting a more environmentally friendly and animal-free protein landscape.
Blykalla is a Swedish company focused on the development and production of advanced small modular reactors (SMRs). Drawing on more than 25 years of research, its reactor concepts aim to provide reliable baseload energy to support a fossil-free energy transition. The company develops lead-cooled reactor designs, featuring cores configured to achieve criticality with enriched uranium oxide fuels, enabling clients to develop, license, and operate small lead-cooled reactors in Sweden. Blykalla emphasizes safety and modularity, offering scalable power solutions for diverse sites while reducing carbon emissions.
BioThrust develops customized gassing solutions for bioreactors.
Saveggy develops an edible, bio-based coating for fruit and vegetables, replacing plastic packaging while maintaining protective properties. This reduces food waste along supply chains and ensures compliance with EU regulations.
Astrape Networks
Grant in 2025
Astrape powers the future of datacenters: more bandwidth, less power.
Nuada is a vertically integrated company specializing in carbon capture technology aimed at decarbonizing heavy industries. The firm develops next-generation point-source capture solutions designed to facilitate energy-efficient CO2 filtration for industrial emitters in sectors that are difficult to decarbonize. By offering innovative technologies, Nuada enables these industries to meet their Net Zero targets while minimizing financial impacts. The company is committed to providing effective environmental solutions that address the challenges of carbon emissions in various industrial applications.
Leyden Labs develops a Mucosal Protection Platform to protect against respiratory viruses, including influenza and coronaviruses. The company offers a portfolio of broad protective nasal sprays designed to reduce the risk of infection and limit transmission, aiming to improve public health through innovative protection methods. Its team combines biotechnology veterans with new talent to advance solutions that address common viral threats at the mucosal surface.
Enairon
Venture Round in 2025
Spira Energy 's technology is focused on a new compressing air concept which creates unique high-efficiency opportunities.
MetisMotion GmbH, founded in 2018 and headquartered in Munich, Germany, specializes in the development of advanced actuators designed for various industrial applications, including robotics, aviation, and automotive sectors. The company focuses on creating lightweight, high force-density actuators that enhance performance through significant reductions in weight and space. MetisMotion's technology integrates the advantages of solid-state actuators with traditional drive systems, facilitating the electrification of hydraulic systems to achieve greater force output and extended displacement capabilities. This innovative approach positions MetisMotion as a key player in driving efficiency and modernization within the actuator market.
Barocal develops innovative cooling technology designed to meet low-carbon refrigeration needs. Its proprietary materials undergo significant thermal changes under pressure application and removal, enhancing energy efficiency and eliminating greenhouse gas warming impact in commercial food and drink refrigeration.
Captor Therapeutics
Grant in 2025
Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.
Targeted Protein Degradation (TPD) combats the therapeutic limits of small molecules with overcoming drug resistance and uncoupling their pharmacokinetics from pharmacodynamics. Breakthrough TPD technology allows degradation of virtually any intracellular protein including the so-called "undruggable proteome".
Laclarée is a French company based in Lyon, founded in 2016, that specializes in developing adaptive eyeglasses specifically designed to correct presbyopia. The company's innovative product incorporates patented fluid technology, allowing the eyeglasses to automatically adjust to different viewing distances in real-time. This advancement aims to address the needs of individuals aged 45 and older who are often dissatisfied with traditional vision correction solutions, such as progressive lenses or the use of multiple pairs of glasses. By combining adaptive lens technology with refractive correction capabilities for conditions like astigmatism, myopia, and hyperopia, Laclarée seeks to provide a more effective solution for clear vision across various distances.
Arctic Therapeutics
Series A in 2025
Arctic Therapeutics is a drug discovery and development company that focuses on identifying the genetic underpinnings of both rare and common diseases. Utilizing bioinformatic approaches and artificial intelligence, the company aims to mitigate the risks associated with traditional drug development while significantly reducing the costs and time required to bring effective treatments to patients. With over 20 years of expertise in international genomics research, Arctic Therapeutics employs an innovative methodology in its drug development efforts. Collaborating closely with the Center for Applied Genomics at the Children's Hospital of Philadelphia, the company is actively involved in repurposing and developing breakthrough medical treatments. Notably, Arctic Therapeutics is working on a drug candidate for Alzheimer’s disease that has the potential to become the first cure for dementia, addressing both treatment and prevention. The company was inspired by Dr. Hakon Hakonarson, a prominent figure in applied genomics, whose work has been recognized as pioneering in the field of genetic research and therapeutic development.
Swave Photonics
Series A in 2025
Swave Photonics designs and markets holographic chips based on proprietary diffractive photonics technology to power compact, lightweight, high-resolution displays that seamlessly blend digital content with the real world. As a fabless semiconductor company, it advances NanoPixel technology to enable immersive holographic displays for augmented reality and metaverse applications, targeting display manufacturers and content creators. The goal is to provide tools that visualize complex content, enable collaboration, and expand possibilities for immersive AR experiences.
Cerabyte specializes in innovative ceramic-based data storage technology, providing a solution for long-term data preservation. This technology is designed to ensure virtually eternal data retention without the need for media replacement, data migration, or energy consumption. By focusing on high performance and quick data access, Cerabyte aims to develop enterprise systems that meet the increasing demands for capacity and efficiency. The company's approach addresses critical challenges faced by data centers, including footprint reduction, performance improvement, and sustainability, enabling businesses to store data in a manner that is both effective and environmentally responsible.
PFx Biotech
Seed Round in 2024
PFx Biotech is a pioneering company that specializes in the development of alternative proteins using precision fermentation. They focus on producing human milk proteins, which are nourishing and contain beneficial bioactivities such as immune-boosting, anti-microbial, and anti-viral properties. By leveraging their fermentation platform, they aim to provide sustainable protein alternatives that can help reduce water consumption and greenhouse gas emissions, thereby promoting a more environmentally friendly and animal-free protein landscape.
PFx Biotech is a pioneering company that specializes in the development of alternative proteins using precision fermentation. They focus on producing human milk proteins, which are nourishing and contain beneficial bioactivities such as immune-boosting, anti-microbial, and anti-viral properties. By leveraging their fermentation platform, they aim to provide sustainable protein alternatives that can help reduce water consumption and greenhouse gas emissions, thereby promoting a more environmentally friendly and animal-free protein landscape.
MindPeak GmbH is a technology company based in Hamburg, Germany, founded in 2018. It specializes in developing artificial intelligence software tools aimed at enhancing the accuracy and efficiency of cancer diagnostics. The company's flagship product, BreastAI, is designed for the quantification of breast cancer immunohistochemistry (IHC) and can be integrated into third-party software systems. MindPeak's solutions automate tissue diagnostics, enabling pathologists to identify and quantify tumorous regions and detect breast cancer cells more effectively. By streamlining tasks such as cell and biomarker quantification, MindPeak's tools allow cancer specialists to focus on critical decision-making in clinical environments, ultimately improving patient care while making diagnostic processes more accessible and cost-effective.
InSpek develops biological and chemical monitoring systems using integrated photonics. The company aims to democratize access to chemical analysis thanks to integrated optics. Its sensors make the most of micro and nano-optical chip technologies to maximize light-matter interactions and improve chemical detection.